News About: Pharm. Industry
AstraZeneca was domestically approved for the atomized-type product of its asthma treatment ‘Symbicort’
The new formulation of the AstraZeneca’s asthma treatment, Symbicort, is about to be launched. Its strength is the easier inhalation with the atomized type than the existing products.
According to the Ministry of Foo...
BMS Korea and its labor union successfully concluded the wage negotiation
BMS Korea (CEO Eun-young Kim) has recently concluded the wage negotiation by signing the 2015 final collective bargaining and wage increase agreement, participated by CEO Eun-young Kim, the union head, Dae-hee Yoo, an...
Multinational pharmaceutical companies, such as MSD, Pfizer, Roche and AZ, are about to compete over immune antibodies
As domestic Phase 3 clinical trials have actively been made for immune antibodies indicated as the new cancer treatment, a new heated competition is expected in the antibody market.
While MSD and Ono have acquired ap...
Approximately 150 domestic and foreign influential pharmaceutical companies will gather in Seoul this September
‘CPhl Korea’ co-hosted by a global exhibition company, UBM, and the Korea Pharmaceutical Traders Associatio(KPTA) will take place at COEX, Seoul from the 7th to 9th of the coming September.
‘CPhl Korea 2014,’ held on...
Private and public organizations joined hands for pharmaceutical exportation, founding GloPharmEx
The Ministry of Food and Drug Safety, the Korea Pharmaceutical Traders Association (KPTA) and domestic pharmaceutical companies are rolling up their sleeves to export domestic pharmaceutical products.
At Intercontine...
Will the pharmaceutical industry, which is busy forming business departments, establish the specialization plan?
According to the industry concerned, some pharmaceutical companies, such as SK Group, Daewoong Pharmaceutical and Kukje Pharm, have either formed a new business department or started to be partially specialized by sel...
The pharmaceutical market grows average 3.5% every year while the market share of generics decreases
It is anticipated that although the volume of the Korean pharmaceutical market has been enlarged, the proportion of generics will decrease.
According to the IMS Health’s report called “IMS Market Prognosis 2015-2019,...
Listed pharmaceutical companies spent more than KRW 100 billion in advertisements on the 1st quarter
It is observed that listed pharmaceutical companies spent more than KRW 100 billion in advertisements on the last 1st quarter, making a 18% increase over the same quarter last year.
According to the YakupDotCom’s ana...
Samsung Biologics attracts the industry by the M&A of Cheil Industries and Samsung C&T Corporation
As the M&A between Cheil Industries and Samsung C&T Corporation is confirmed, growth of Samsung Biologics is expected to be accelerated.
Samsung Group, planning to complete the M&A of Cheil Industries and Samsung C&T...
Will unprecedented movements of Alvogen bear fruit?
The American generic-centered pharmaceutical company, Alvogen, is about to finish its 3-year expansion project to the Korean market, and started to move towards the new goal to become the top 5 in the Asia-Pacific reg...
